FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
the finding matters only as far as its evidence, limitations and independent verification can carry it.
By Nivegu News Desk
What happened
FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A.
Why it matters
the finding matters only as far as its evidence, limitations and independent verification can carry it.
What happens next
peer review, replication and disclosed uncertainty.